▶ 調査レポート

十二指腸潰瘍治療の世界市場(~2026年)

• 英文タイトル:Global Duodenal Ulcer Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。十二指腸潰瘍治療の世界市場(~2026年) / Global Duodenal Ulcer Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY11728資料のイメージです。• レポートコード:MRC2-11QY11728
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は十二指腸潰瘍治療のグローバル市場について調査・分析したレポートです。種類別(抗生物質、プロトンポンプ阻害剤、制酸剤、カリウム競合性酸遮断薬(P-CAB)、H2拮抗薬、潰瘍保護薬、手術)市場規模、用途別(病院・クリニック、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別十二指腸潰瘍治療の競争状況、市場シェア
・世界の十二指腸潰瘍治療市場:種類別市場規模 2015年-2020年(抗生物質、プロトンポンプ阻害剤、制酸剤、カリウム競合性酸遮断薬(P-CAB)、H2拮抗薬、潰瘍保護薬、手術)
・世界の十二指腸潰瘍治療市場:種類別市場規模予測 2021年-2026年(抗生物質、プロトンポンプ阻害剤、制酸剤、カリウム競合性酸遮断薬(P-CAB)、H2拮抗薬、潰瘍保護薬、手術)
・世界の十二指腸潰瘍治療市場:用途別市場規模 2015年-2020年(病院・クリニック、その他)
・世界の十二指腸潰瘍治療市場:用途別市場規模予測 2021年-2026年(病院・クリニック、その他)
・北米の十二指腸潰瘍治療市場分析:米国、カナダ
・ヨーロッパの十二指腸潰瘍治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの十二指腸潰瘍治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の十二指腸潰瘍治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの十二指腸潰瘍治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):GlaxoSmithKline、Pfizer、Abbott Laboratories、Merck、Nihon Pharmaceuticals、Novartis、Bristol Meyer Squibb、AstraZeneca、Takeda、Ei Sai
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Duodenal ulcer is a sore occurring in the upper area of the small intestine, the duodenum.
Globally demand for duodenal ulcer treatment is expected to witness growth due to increasing prevalence of the disease.

Market Analysis and Insights: Global Duodenal Ulcer Treatment Market
The global Duodenal Ulcer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Duodenal Ulcer Treatment Scope and Market Size
Duodenal Ulcer Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Duodenal Ulcer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
GlaxoSmithKline
Pfizer
Abbott Laboratories
Merck
Nihon Pharmaceuticals
Novartis
Bristol Meyer Squibb
AstraZeneca
Takeda
Ei Sai

Market segment by Type, the product can be split into
Antibiotics
Proton Pump Inhibitors
Antacids
Potassium-Competitive Acid Blockers (P-CAB)
H2-Antagonist
Ulcer Protective Drugs
Surgery
Market segment by Application, split into
Hospitals and Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Duodenal Ulcer Treatment Revenue
1.4 Market by Type
1.4.1 Global Duodenal Ulcer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibiotics
1.4.3 Proton Pump Inhibitors
1.4.4 Antacids
1.4.5 Potassium-Competitive Acid Blockers (P-CAB)
1.4.6 H2-Antagonist
1.4.7 Ulcer Protective Drugs
1.4.8 Surgery
1.5 Market by Application
1.5.1 Global Duodenal Ulcer Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Duodenal Ulcer Treatment Market Perspective (2015-2026)
2.2 Global Duodenal Ulcer Treatment Growth Trends by Regions
2.2.1 Duodenal Ulcer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Duodenal Ulcer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Duodenal Ulcer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Duodenal Ulcer Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Duodenal Ulcer Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Duodenal Ulcer Treatment Players by Market Size
3.1.1 Global Top Duodenal Ulcer Treatment Players by Revenue (2015-2020)
3.1.2 Global Duodenal Ulcer Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Duodenal Ulcer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Duodenal Ulcer Treatment Market Concentration Ratio
3.2.1 Global Duodenal Ulcer Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Duodenal Ulcer Treatment Revenue in 2019
3.3 Duodenal Ulcer Treatment Key Players Head office and Area Served
3.4 Key Players Duodenal Ulcer Treatment Product Solution and Service
3.5 Date of Enter into Duodenal Ulcer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Duodenal Ulcer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Duodenal Ulcer Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Duodenal Ulcer Treatment Market Size by Application (2015-2020)
5.2 Global Duodenal Ulcer Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Duodenal Ulcer Treatment Market Size (2015-2020)
6.2 Duodenal Ulcer Treatment Key Players in North America (2019-2020)
6.3 North America Duodenal Ulcer Treatment Market Size by Type (2015-2020)
6.4 North America Duodenal Ulcer Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Duodenal Ulcer Treatment Market Size (2015-2020)
7.2 Duodenal Ulcer Treatment Key Players in Europe (2019-2020)
7.3 Europe Duodenal Ulcer Treatment Market Size by Type (2015-2020)
7.4 Europe Duodenal Ulcer Treatment Market Size by Application (2015-2020)

8 China
8.1 China Duodenal Ulcer Treatment Market Size (2015-2020)
8.2 Duodenal Ulcer Treatment Key Players in China (2019-2020)
8.3 China Duodenal Ulcer Treatment Market Size by Type (2015-2020)
8.4 China Duodenal Ulcer Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Duodenal Ulcer Treatment Market Size (2015-2020)
9.2 Duodenal Ulcer Treatment Key Players in Japan (2019-2020)
9.3 Japan Duodenal Ulcer Treatment Market Size by Type (2015-2020)
9.4 Japan Duodenal Ulcer Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Duodenal Ulcer Treatment Market Size (2015-2020)
10.2 Duodenal Ulcer Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Duodenal Ulcer Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Duodenal Ulcer Treatment Market Size by Application (2015-2020)

11 India
11.1 India Duodenal Ulcer Treatment Market Size (2015-2020)
11.2 Duodenal Ulcer Treatment Key Players in India (2019-2020)
11.3 India Duodenal Ulcer Treatment Market Size by Type (2015-2020)
11.4 India Duodenal Ulcer Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Duodenal Ulcer Treatment Market Size (2015-2020)
12.2 Duodenal Ulcer Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Duodenal Ulcer Treatment Market Size by Type (2015-2020)
12.4 Central & South America Duodenal Ulcer Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Duodenal Ulcer Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Duodenal Ulcer Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Duodenal Ulcer Treatment Introduction
13.2.4 Pfizer Revenue in Duodenal Ulcer Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Details
13.3.2 Abbott Laboratories Business Overview
13.3.3 Abbott Laboratories Duodenal Ulcer Treatment Introduction
13.3.4 Abbott Laboratories Revenue in Duodenal Ulcer Treatment Business (2015-2020)
13.3.5 Abbott Laboratories Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Duodenal Ulcer Treatment Introduction
13.4.4 Merck Revenue in Duodenal Ulcer Treatment Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Nihon Pharmaceuticals
13.5.1 Nihon Pharmaceuticals Company Details
13.5.2 Nihon Pharmaceuticals Business Overview
13.5.3 Nihon Pharmaceuticals Duodenal Ulcer Treatment Introduction
13.5.4 Nihon Pharmaceuticals Revenue in Duodenal Ulcer Treatment Business (2015-2020)
13.5.5 Nihon Pharmaceuticals Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview
13.6.3 Novartis Duodenal Ulcer Treatment Introduction
13.6.4 Novartis Revenue in Duodenal Ulcer Treatment Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Bristol Meyer Squibb
13.7.1 Bristol Meyer Squibb Company Details
13.7.2 Bristol Meyer Squibb Business Overview
13.7.3 Bristol Meyer Squibb Duodenal Ulcer Treatment Introduction
13.7.4 Bristol Meyer Squibb Revenue in Duodenal Ulcer Treatment Business (2015-2020)
13.7.5 Bristol Meyer Squibb Recent Development
13.8 AstraZeneca
13.8.1 AstraZeneca Company Details
13.8.2 AstraZeneca Business Overview
13.8.3 AstraZeneca Duodenal Ulcer Treatment Introduction
13.8.4 AstraZeneca Revenue in Duodenal Ulcer Treatment Business (2015-2020)
13.8.5 AstraZeneca Recent Development
13.9 Takeda
13.9.1 Takeda Company Details
13.9.2 Takeda Business Overview
13.9.3 Takeda Duodenal Ulcer Treatment Introduction
13.9.4 Takeda Revenue in Duodenal Ulcer Treatment Business (2015-2020)
13.9.5 Takeda Recent Development
13.10 Ei Sai
13.10.1 Ei Sai Company Details
13.10.2 Ei Sai Business Overview
13.10.3 Ei Sai Duodenal Ulcer Treatment Introduction
13.10.4 Ei Sai Revenue in Duodenal Ulcer Treatment Business (2015-2020)
13.10.5 Ei Sai Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Duodenal Ulcer Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Duodenal Ulcer Treatment Revenue
Table 3. Ranking of Global Top Duodenal Ulcer Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Duodenal Ulcer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibiotics
Table 6. Key Players of Proton Pump Inhibitors
Table 7. Key Players of Antacids
Table 8. Key Players of Potassium-Competitive Acid Blockers (P-CAB)
Table 9. Key Players of H2-Antagonist
Table 10. Key Players of Ulcer Protective Drugs
Table 11. Key Players of Surgery
Table 12. Global Duodenal Ulcer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Duodenal Ulcer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Duodenal Ulcer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Duodenal Ulcer Treatment Market Share by Regions (2015-2020)
Table 16. Global Duodenal Ulcer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Duodenal Ulcer Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Duodenal Ulcer Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Duodenal Ulcer Treatment Players
Table 23. Global Duodenal Ulcer Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Duodenal Ulcer Treatment Market Share by Players (2015-2020)
Table 25. Global Top Duodenal Ulcer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Duodenal Ulcer Treatment as of 2019)
Table 26. Global Duodenal Ulcer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Duodenal Ulcer Treatment Product Solution and Service
Table 29. Date of Enter into Duodenal Ulcer Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Duodenal Ulcer Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Duodenal Ulcer Treatment Market Size Share by Type (2015-2020)
Table 33. Global Duodenal Ulcer Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Duodenal Ulcer Treatment Market Size Share by Application (2015-2020)
Table 35. Global Duodenal Ulcer Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Duodenal Ulcer Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Duodenal Ulcer Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Duodenal Ulcer Treatment Market Share (2019-2020)
Table 39. North America Duodenal Ulcer Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Duodenal Ulcer Treatment Market Share by Type (2015-2020)
Table 41. North America Duodenal Ulcer Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Duodenal Ulcer Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Duodenal Ulcer Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Duodenal Ulcer Treatment Market Share (2019-2020)
Table 45. Europe Duodenal Ulcer Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Duodenal Ulcer Treatment Market Share by Type (2015-2020)
Table 47. Europe Duodenal Ulcer Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Duodenal Ulcer Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Duodenal Ulcer Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Duodenal Ulcer Treatment Market Share (2019-2020)
Table 51. China Duodenal Ulcer Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Duodenal Ulcer Treatment Market Share by Type (2015-2020)
Table 53. China Duodenal Ulcer Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Duodenal Ulcer Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Duodenal Ulcer Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Duodenal Ulcer Treatment Market Share (2019-2020)
Table 57. Japan Duodenal Ulcer Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Duodenal Ulcer Treatment Market Share by Type (2015-2020)
Table 59. Japan Duodenal Ulcer Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Duodenal Ulcer Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Duodenal Ulcer Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Duodenal Ulcer Treatment Market Share (2019-2020)
Table 63. Southeast Asia Duodenal Ulcer Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Duodenal Ulcer Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Duodenal Ulcer Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Duodenal Ulcer Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Duodenal Ulcer Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Duodenal Ulcer Treatment Market Share (2019-2020)
Table 69. India Duodenal Ulcer Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Duodenal Ulcer Treatment Market Share by Type (2015-2020)
Table 71. India Duodenal Ulcer Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Duodenal Ulcer Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Duodenal Ulcer Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Duodenal Ulcer Treatment Market Share (2019-2020)
Table 75. Central & South America Duodenal Ulcer Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Duodenal Ulcer Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Duodenal Ulcer Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Duodenal Ulcer Treatment Market Share by Application (2015-2020)
Table 79. GlaxoSmithKline Company Details
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Product
Table 82. GlaxoSmithKline Revenue in Duodenal Ulcer Treatment Business (2015-2020) (Million US$)
Table 83. GlaxoSmithKline Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Product
Table 87. Pfizer Revenue in Duodenal Ulcer Treatment Business (2015-2020) (Million US$)
Table 88. Pfizer Recent Development
Table 89. Abbott Laboratories Company Details
Table 90. Abbott Laboratories Business Overview
Table 91. Abbott Laboratories Product
Table 92. Abbott Laboratories Revenue in Duodenal Ulcer Treatment Business (2015-2020) (Million US$)
Table 93. Abbott Laboratories Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Product
Table 97. Merck Revenue in Duodenal Ulcer Treatment Business (2015-2020) (Million US$)
Table 98. Merck Recent Development
Table 99. Nihon Pharmaceuticals Company Details
Table 100. Nihon Pharmaceuticals Business Overview
Table 101. Nihon Pharmaceuticals Product
Table 102. Nihon Pharmaceuticals Revenue in Duodenal Ulcer Treatment Business (2015-2020) (Million US$)
Table 103. Nihon Pharmaceuticals Recent Development
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Product
Table 107. Novartis Revenue in Duodenal Ulcer Treatment Business (2015-2020) (Million US$)
Table 108. Novartis Recent Development
Table 109. Bristol Meyer Squibb Company Details
Table 110. Bristol Meyer Squibb Business Overview
Table 111. Bristol Meyer Squibb Product
Table 112. Bristol Meyer Squibb Revenue in Duodenal Ulcer Treatment Business (2015-2020) (Million US$)
Table 113. Bristol Meyer Squibb Recent Development
Table 114. AstraZeneca Business Overview
Table 115. AstraZeneca Product
Table 116. AstraZeneca Company Details
Table 117. AstraZeneca Revenue in Duodenal Ulcer Treatment Business (2015-2020) (Million US$)
Table 118. AstraZeneca Recent Development
Table 119. Takeda Company Details
Table 120. Takeda Business Overview
Table 121. Takeda Product
Table 122. Takeda Revenue in Duodenal Ulcer Treatment Business (2015-2020) (Million US$)
Table 123. Takeda Recent Development
Table 124. Ei Sai Company Details
Table 125. Ei Sai Business Overview
Table 126. Ei Sai Product
Table 127. Ei Sai Revenue in Duodenal Ulcer Treatment Business (2015-2020) (Million US$)
Table 128. Ei Sai Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Duodenal Ulcer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Antibiotics Features
Figure 3. Proton Pump Inhibitors Features
Figure 4. Antacids Features
Figure 5. Potassium-Competitive Acid Blockers (P-CAB) Features
Figure 6. H2-Antagonist Features
Figure 7. Ulcer Protective Drugs Features
Figure 8. Surgery Features
Figure 9. Global Duodenal Ulcer Treatment Market Share by Application: 2020 VS 2026
Figure 10. Hospitals and Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Duodenal Ulcer Treatment Report Years Considered
Figure 13. Global Duodenal Ulcer Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Duodenal Ulcer Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Duodenal Ulcer Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Duodenal Ulcer Treatment Market Share by Players in 2019
Figure 18. Global Top Duodenal Ulcer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Duodenal Ulcer Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Duodenal Ulcer Treatment Revenue in 2019
Figure 20. North America Duodenal Ulcer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Duodenal Ulcer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Duodenal Ulcer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Duodenal Ulcer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Duodenal Ulcer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Duodenal Ulcer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Duodenal Ulcer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed